David Cameron has defended British drugs company GlaxoSmithKline, which came under fire in July for a bribery scandal within its Chinese business. Chinese employees of the...
Mike Appleby, a sustainable and responsible investment (SRI) analyst at Alliance Trust, explains how the investment house squares pharmaceuticals firm GlaxoSmithKline’s status as a viable sustainable...
British drug company GlaxoSmithKline (GSK) has come under fire over allegations of bribery in China. But investors still trust the company, which remains a popular choice...